Chronic obstructive pulmonary disease (COPD) stands as one of the leading causes of mortality worldwide. Acute exacerbations of COPD (AECOPD) lead to rapid respiratory function decline and worsened disease status. Despite recent studies, the ability of the neutrophil-to-lymphocyte ratio (NLR) to predict outcomes in patients with COPD remains controversial. We investigated the predictive value of NLR for adverse outcomes in hospitalized patients with AECOPD. A retrospective study was conducted at the Department of Pulmonary Medicine, Cho Ray Hospital (Vietnam) from November 2019 to November 2021. The study extracted data from patients diagnosed with AECOPD at discharge and met the inclusion criteria. NLR is calculated by dividing the number of neutrophils by the number of lymphocytes in the peripheral blood test. Adverse outcomes are defined as invasive mechanical ventilation, admission to intensive care unit, or in-hospital mortality. Multivariable regression analysis was conducted to identify variables predicting adverse outcomes. The cutoff, sensitivity, specificity, area under the curve, and receiver operating characteristic of NLR were determined for predicting adverse outcomes. Two hundred eighty-seven patients with AECOPD were included in the final analysis, with a mean age of 70.9, and males comprising 92.7%. The rate of adverse outcomes was 15.7%. Multivariable logistic regression identified reduced consciousness at admission (adjusted odds ratio = 0.08, 95% confidence interval [CI]: 0.02–0.38, P = .001) and high NLR (adjusted odds ratio = 1.17, 95% CI: 1.10–1.24, P < .001) as predictors of adverse outcomes. The receiver operating characteristic of NLR’s predictive value yielded an area under the curve of 0.877 (95% CI: 0.83–0.93). An NLR cutoff of 11.0 predicted adverse outcomes with a sensitivity of 80.0%, specificity of 77.7%, and an odds ratio of 13.9 (95% CI: 6.3–30.7), P < .001. NLR is a simple, routine, and cost-effective tool for predicting adverse outcomes in hospitalized patients with AECOPD. Future studies should evaluate the kinetics of NLR in predicting treatment response in patients with AECOPD.
Rationale: Among 3 forms of mercury, elemental mercury vapor presents the highest threat due to its potential to cause acute pneumonitis. The management of acute mercury vapor poisoning remains unclear, particularly in acute lung injury. We present a case of mercury vapor poisoning resulting from the heating of cinnabar, successfully treated with high-dose corticosteroids and chelation therapy, and follow-up over 6 months. Patient concerns: A 47-year-old female patient was admitted to the Emergency Department due to dyspnea, chest tightness, and weakness following cinnabar heating. Diagnoses: Upon admission, she presented with tachypnea and respiratory failure. During the first 5 days, the respiratory failure rapidly progressed, requiring high-flow nasal cannula support, and showed no improvement with broad-spectrum intravenous (IV) antibiotics and 80 mg daily IV methylprednisolone. Total blood and urinary mercury levels were measured to confirm the diagnosis. Interventions: Upon confirmation of acute pneumonitis due to mercury vapor poisoning, the patient was administered high-dose methylprednisolone (500 mg IV per day) and chelation therapy, which led to subsequent improvement. Outcomes: Six months after discharge, the patient completely recovered, as evidenced by chest imaging and pulmonary function tests. Lessons: Heating elemental mercury can cause pneumonitis, leading to acute respiratory failure. A detailed history is crucial for diagnosis. High-dose methylprednisolone should be considered in patients who do not respond to lower doses. Patients should be monitored afterward to detect residual pulmonary fibrotic changes.
Necrotizing pneumonia (NP) is characterized by destruction of pulmonary tissue, resulting in multiple thin-walled cavities. There are limited reports on NP and parapneumonic effusion cases in children associated with Pseudomonas aeruginosa. Currently, there is no consensus regarding the optimal timing for video-assisted thoracoscopic surgery (VATS) following failure of chest tube placement and antibiotic treatment. A healthy 20-month-old child was hospitalized with symptoms of community-acquired pneumonia, progressing to severe NP and parapneumonic effusion. Despite receiving broad-spectrum antibiotics and chest tube placement on the third day of treatment, the condition continued to deteriorate, prompting VATS intervention on the sixth day. The presence of a “split pleural sign“ and extensive lung necrosis on chest computed tomography contributed to initial treatment failure. Multidrug resistance P. aeruginosa was identified through nasal trachea aspiration specimens on the eighth day of treatment, leading to an adjustment in antibiotic therapy to high-dose meropenem and amikacin. Subsequently, the patient became afebrile, showed clinical improvement, and was discharged after 35 days of treatment. Through this case, we aim to emphasize an unusual pathogenic bacteria in the context of NP and the need for standardized surgical interventions in pediatric patients with NP.
Introduction and Importance: Electrocution can lead to severe visceral organ damage, including pulmonary injuries. However, isolated electrical-induced pulmonary injury (EIPI) following electric shock remains underreported. This case reports a 33-year-old male who suffered an EIPI after contact with low-voltage electricity and provides a comprehensive literature review to explore the mechanisms, clinical presentation, imaging findings, and treatment of EIPI. Case Presentation: A previously healthy 33-year-old male presented with dyspnea, chest pain, and dry cough following an electrocution while lifting a fallen 220 V wire. Chest imaging revealed diffuse consolidations, ground-glass opacities (GGO), and interlobular septal thickening. Bronchoscopy findings were normal; no infectious pathogens were detected in blood and sputum cultures. The patient was treated with oxygen therapy, antibiotics, and supportive care, achieving full recovery after 9 days of hospitalization. Clinical Discussion: A review of 12 case reports found that pulmonary injuries following electrocution are mostly associated with low-voltage exposure. The most common findings include bilateral lung consolidations, GGO, and diffuse alveolar hemorrhage. The pathophysiology of lung parenchyma involves coagulation necrosis, leading to alveolar hemorrhage. Management includes supportive care, with surgery reserved for cases with extensive necrosis unresponsive to medical treatment. Conclusion: EIPI is a rare but potentially severe consequence of electrocution, often presenting as bilateral lung consolidations and alveolar hemorrhage. Given the variability in presentation and severity, chest imaging should be considered in all cases after electrocution, even in the absence of external injuries. Early recognition and appropriate treatment are essential to ensure favorable outcomes, with surgical intervention considered in selected cases.
Infections caused by Nocardia species are relatively rare and primarily affect immunocompromised patients. There are few reported cases of Nocardia beijingensis causing empyema in patients with systemic lupus erythematosus (SLE). We present a case of a 49-year-old female patient with SLE on immunosuppressive therapy (corticosteroids and azathioprine), admitted with dyspnea and left-sided pleuritic chest pain. A diagnosis of large parapneumonic left pleural effusion was established based on blood tests, blind thoracentesis findings, and bronchoalveolar lavage results. The patient received empirical intravenous antibiotic therapy with imipenem/cilastatin and vancomycin without isolating the causative organism for 10 days. Three weeks postdischarge, the patient's left pleuritic chest pain worsened, prompting chest computed tomography that revealed multiple loculated pleural-abdominal wall fluid collections. Ultrasound-guided aspiration of these areas yielded pus cultured positive for N. beijingensis. The patient showed improvement following treatment with imipenem/cilastatin and trimethoprim/sulfamethoxazole. This case represents a rare manifestation of N. beijingensis causing pleural and abdominal wall empyema. Ultrasound-guided aspiration, targeting the loculated and encapsulated effusion, played a crucial role in confirming the diagnosis. Empirical treatment with imipenem/cilastatin combined with long-term oral trimethoprim/sulfamethoxazole was found to be effective.
Rationale: Aspiration of gastric contents (Mendelson syndrome) can cause chemical pneumonitis and quickly progress to acute respiratory distress syndrome (ARDS). Evidence for corticosteroids in this setting is limited, and guidelines are unclear. We describe a postpartum case of aspiration pneumonitis evolving to ARDS that improved after a short course of methylprednisolone. Patient concerns: A 27-year-old woman developed severe dyspnea, chest tightness, and hypoxemia after a cesarean section performed under general anesthesia. Diagnoses: On arrival at Cho Ray Hospital, she was tachypneic with bilateral crackles and a PaO 2 /FiO 2 ratio of 78.4. Chest radiography showed diffuse bilateral infiltrates, and bronchoscopy revealed edematous, secretion-free airways, findings consistent with aspiration pneumonitis progressing to early ARDS. Interventions: The patient was intubated, treated with lung-protective mechanical ventilation, broad-spectrum antibiotics, supportive care, and intravenous methylprednisolone at 1 mg/kg/day for 2 days. Outcomes: Oxygenation indices rose rapidly after steroid initiation, allowing stepwise ventilator weaning. She was extubated on day 5 and discharged on day 10 without respiratory symptoms, and postpartum recovery was uneventful. Lessons: Mendelson syndrome can progress within hours to severe ARDS even in otherwise healthy postpartum patients. Early airway protection with lung-protective ventilation, consideration of early bronchoscopy when feasible, and stewardship-based empiric antibiotics with de-escalation are important. A carefully monitored, time-limited corticosteroid trial may be considered in selected cases of chemical aspiration-related moderate to severe ARDS, but treatment should be individualized with close reassessment.